CytoPherx

company

About

CytoPherx is a medical device company offering a proprietary selective cytopheresis sytem for inflammation-based diseases and conditions.

  • 1 - 10

Details

Last Funding Type
Series B
Last Funding Money Raised
$11.70M
Industries
Health Care,Life Science,Medical Device
Founded date
Jan 1, 2007
Number Of Employee
1 - 10
Operating Status
Active

CytoPherx (formerly Nephrion) clinical stage medical device company addressing inflammation-based diseases and conditions. The company’s products are custom configurations of a proprietary selective cytopheresis-based inflammation modulating system.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$11.70M
CytoPherx has raised a total of $11.70M in funding over 2 rounds. Their latest funding was raised on Jun 17, 2010 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 17, 2010 Series B $11.70M 1 Diamond Capital Management Detail

Investors

Number of Lead Investors
Number of Investors
1
1
CytoPherx is funded by 1 investors. Diamond Capital Management are the most recent investors.
Investor Name Lead Investor Funding Round
Diamond Capital Management Yes Series B